logo
Plus   Neg
Share
Email

ACEA Biosciences To Be Acquired By Agilent - Quick Facts

ACEA Biosciences announced that it has signed a definitive agreement to join Agilent Technologies, Inc. (A). ACEA Biosciences is a company known for developing products, which are used in academia, as well as the biotech and pharmaceutical industries. ACEA's xCELLigence impedance-based, label-free, real-time cell analysis instruments and NovoCyte flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research.

"The analytical instruments, systems, and software developed by ACEA dovetail perfectly with the strategic vision and mission of Agilent Technologies. Agilent also has a number of complementary technologies, used in immuno-oncology and drug discovery, which should provide tremendous synergies," said Xiao Xu, CEO of ACEA.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alibaba is upgrading its intellectual property system using blockchain technology, according to local news outlet Sohu. Alibaba Platform Management expects this to benefit mainly small and medium-sized enterprises, brands and entrepreneurs. The technology will be fully implemented in September, and thereafter, the company intends to expand it to the field of digital copyright protection. Electronics retailer Best Buy Co., Inc. (BBY) reported Thursday a 27 percent increase in profit for the first quarter from last year, which was impacted by restructuring charges, and higher revenues. Both adjusted earnings per share and revenues for the quarter topped analysts' estimates. The company also provides guidance for the second quarter and reiterated its outlook for the full-year 2020. While reporting financial results for the second quarter on Thursday, Hormel Foods Corp. (HRL) lowered its earnings and net sales guidance for the full-year 2019. For fiscal 2019, the company now projects earnings in a range of $1.71 to $1.85 per share, and net sales between $9.70 billion and $10.20...
Follow RTT